Stock information

Idogen is listed on Nasdaq First North Growth Market. See stock information here

Insider tradings

Notification of insider trading exceeding 5000 Euro per year in Idogen should be made to Finansinspektionen and to Idogen at insynsanmalan at idogen dot com.
See Finansinspektionen’s insider registry here:

Finansinspektionens insynsregister

Idogen develops tolerogenic cell therapy – Individualised treatment for each patient